|
|
|
|
LEADER |
01018naa a2200289 i 4500 |
001 |
NSK01001006211 |
003 |
HR-ZaNSK |
005 |
20180906112926.0 |
007 |
ta |
008 |
180906s2017 ci | |1|| ||eng |
035 |
|
|
|a (HR-ZaNSK)001006211
|
040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
042 |
|
|
|a croatica
|
044 |
|
|
|a ci
|c hr
|
080 |
1 |
|
|a 615
|2 2011
|
100 |
1 |
|
|a Najim, Hellme
|4 aut
|
245 |
1 |
0 |
|a Does risperidone long acting injectable depot (RLAI) reduce number of admissions to hospital /
|c Hellme Najim, Ashish Pathak, Andrea Pathak.
|
300 |
|
|
|b Ilustr.
|
500 |
|
|
|a 6th Cambridge International Conference on Mental Health, Cambridge, 22-22nd September 2017
|
504 |
|
|
|a Bibliografija: 16 jed.
|
653 |
|
0 |
|a Risperidon
|a Liječenje
|a Shizofrenija
|a Hospitalizacija
|
653 |
|
5 |
|a Engleska
|
700 |
1 |
|
|a Pathak, Ashish
|4 aut
|
700 |
1 |
|
|a Pathak, Andrea
|4 aut
|
773 |
0 |
|
|t Psychiatria Danubina. Supplement
|x 1332-1366
|g 29 (2017), 3 ; str. 652-655
|w nsk.(HR-ZaNSK)000009867
|
981 |
|
|
|b B01/17
|
998 |
|
|
|b mamo1809
|